Contact Us
Find A Doctor

SOLX IOP Clinical Trial

Principal Investigator 

Celso Tello, M.D.

Objective

The Gold Shunt is a Randomized, controlled, multi center trial to evaluate the Solx Gold Shunt for the reduction of Intra Ocular Pressure (IOP) in Glaucomatous eyes following failed medical and conventional surgical treatments.

Eligibility

To Be eligible for the trial you must be older than 18 years old, IOP higher than 22 and 23 ,have a failed trabeculectomy, be compliant with your appointments, and follow ups , and be willing to sign a consent to be follow for at least 2 years, VA of 20 /40 or worse.

Enrollment Goal

20 participants (OPEN)

 

Contact Us

Glaucoma Associates of New York - Glaucoma Research InstituteTel: (212) 477-7540 ext 329

Address310 E. 14th Street
South Building, 5th Floor
New York, NY 10003

View all locations